Dr. Gaylis has presented numerous scientific papers at medical meetings around the world, and is the author of a number of research articles on rheumatoid arthritis and systemic lupus erythematosus. Actively involved in ongoing clinical research trials studying a variety of arthritis drugs and other treatments, Dr. Gaylis was/is a principal investigator in the research of over 100 new pharmaceutical products for the treatment of rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus, lupus nephritis, gout and Sjogren’s syndrome.
Dr. Gaylis is a medical graduate of the University of Witwatersrand, Johannesburg, South Africa, and completed his residency in Internal Medicine and a fellowship in rheumatology in Miami. He is the owner and Chief Operating Partner of Arthritis & Rheumatic Disease Specialties. He was a past President of the Florida Society of Rheumatology. He is a regularly featured speaker, nationally and internationally, on multiple topics in rheumatology including the use of EMRI technology in rheumatoid arthritis, for which he is internationally known.